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ABSTRACT
Diagnosis is a cornerstone of clinical practice for mental healthcare 
providers. Yet traditional diagnostic systems have shortcomings, including 
inadequate reliability, high co-morbidity, and marked diagnostic 
heterogeneity. The Hierarchical Taxonomy of Psychopathology (HiTOP) is a 
data-driven, hierarchically-based alternative to classification that 
conceptualizes psychopathology as a set of dimensional symptoms 
organized into increasingly broad, transdiagnostic spectra. Prior work has 
shown it improves reliability and validity, but translating a model like HiTOP 
into a workable system that is useful for treatment providers remains a 
challenge. To this end, the present work outlines the model and its major 
principles to guide integration of HiTOP into clinical practice. We illustrate 
what an approach like HiTOP would look like in practice relative to traditional
nosology, and review advantages and limits for its clinical utility, including 
case conceptualization and treatment planning. Finally, we address 
commonly perceived barriers to its clinical integration.
Keywords: Nosology, Classification, Psychopathology, Diagnosis
Significance: Redefining a taxonomy of psychopathology along empirical 
grounds results in dimensions, not categories, that can be organized 
hierarchically—with at least six higher-level spectra near the top of the 
model and more specific lower-level components and traits at the bottom. 
This approach fosters integrated case conceptualizations and can align more 
closely with transdiagnostic treatments, while maintaining flexibility to define
more narrow targets for intervention. Case illustration shows how a model 
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like HiTOP can be used in clinical practice today, although more work is 
needed to establish it will improve clinical utility.
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Integrating the Hierarchical Taxonomy of Psychopathology (HiTOP)
into Clinical Practice
A reliable, valid, and clinically useful classification system for mental 
illness is a cornerstone of clinical practice in the ideal (Kendell & Jablensky, 
2003; Krueger et al., 2018; Mullins-Sweatt & Widiger, 2009). It facilitates 
communication, orients and guides treatment planning, and serves as a 
common basis for administering care. It also can provide information about 
the natural course of illness against which to measure the effectiveness of 
treatment as well as create a foundation for research (APA, 2006; APA, 2013;
First et al., 2014). In contemporary mental healthcare systems, diagnosis has
overwhelmingly meant using some version of the Diagnostic and Statistical 
Manual of Mental Disorders (DSM; APA, 2006) or the International Statistical 
Classification of Diseases and Related Health Problems (ICD; WHO, 1992). 
However, these nosologies can fall short of ideals (Clark, Watson, & 
Reynolds, 1995; Krueger et al., 2018). Excessive co-occurrence of disorders 
(i.e. comorbidity) contributes to doubt regarding their distinctiveness (Clark, 
Cuthbert, Lewis-Fernández, Narrow, & Reed, 2017). Alternatively, marked 
within-diagnosis heterogeneity means that individuals with the same 
diagnosis can have different sets of symptoms (e.g., thousands of unique 
symptom presentations for a given diagnosis; Galatzer-Levy & Bryant, 2013),
so the pathophysiology, clinical course, and treatment of choice for patients 
with the same diagnostic label may differ dramatically (Hasler, Drevets, 
Manji, & Charney, 2004; Olbert, Gala, & Tupler, 2014; Shackman & Fox, 
2018; Zimmerman, Ellison, Young, Chelminski, & Dalrymple, 2015). 
Reliability for several diagnostic categories is low (e.g., ~40% of diagnoses 
examined in the DSM-5 field trials did not show acceptable inter-rater 
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agreement; Chmielewski, Clark, Bagby, & Watson, 2015; Regier et al., 2013),
although not out of line with estimates for diagnoses from other areas of 
medicine (Kraemer, Kupfer, Clarke, Narrow, & Regier, 2012). Finally, 
traditional systems define mental disorders in terms of strictly demarcated 
categories of mental illness, yet it has been recognized that most 
psychopathology falls along a continuum with normality, without the sharp 
break implied by categorical nosologies (e.g., Carragher et al., 2014; Haslam,
Holland, & Kuppens, 2012; Kent & Rosanoff, 1910; Markon, Chmielewski, & 
Miller, 2011; Walton, Ormel, & Krueger, 2011; Wright et al., 2013). 
Critically, there are concerns regarding the clinical utility of the DSM 
and ICD. Practicing clinicians frequently do not assess diagnostic criteria 
methodically, often lacking the time or motivation to do so (Beutler & Malik, 
2002; Blashfield & Herkov, 1996; Bostic & Rho, 2006; Bruchmüller, Margraf, 
& Schneider, 2012; Hermes, Sernyak, & Rosenheck, 2013; Mohamed & 
Rosenheck, 2008; Morey & Benson, 2016; Morey & Ochoa, 1989; Taylor, 
2016; Waszczuk et al., 2017; Zimmerman & Galione, 2010), although this 
concern may not be unique to DSM and ICD but be a problem for any 
nosology.  For many disorders, the most frequently used diagnosis is Other 
Specified/Unspecified (Not Otherwise Specified in previous editions of the 
DSM; Machado, Machado, Gonçalves, & Hoek, 2007; Verheul & Widiger, 
2004), meaning the patient’s presentation does not fit any specific category. 
Moreover, the DSM and ICD categories provide little diagnosis-specific 
information to guide treatment decisions (First et al., 2018). Most categories 
have a wide range of applicable treatments, with many pharmaceutical and 
psychosocial treatments showing transdiagnostic effects (Barlow, Sauer-
Zavala, Carl, Bullis, & Ellard, 2013). Indeed, a driving force for assigning a 
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patient a DSM or ICD diagnosis may often be less about clinical care and 
more about administrative or reimbursement requirements (Braun & Cox, 
2005; Eriksen & Kress, 2004; First et al., 2018; Mead, Hohenshil, & Singh, 
1997; Welfel, 2010; Zimmerman, Jampala, Sierles, & Taylor, 1993). 
Quantitative nosology as an empirically based alternative
Quantitative nosology offers a data-driven alternative to traditional 
classification of mental illness that can address some of its limitations and 
foster transdiagnostic conceptualizations of mental illness that may better 
align with clinical practice. It is focused on identifying empirical 
constellations of co-occurring signs, symptoms, and maladaptive behaviors, 
and classifying psychopathology accordingly (Kotov et al., 2017; Krueger et 
al., 2018). Unlike prevailing nosologies that rely heavily on expert consensus,
quantitative nosology seeks an empirically-based solution to classification. 
Statistical analyses guides the grouping of symptoms into coherent 
dimensional symptom components and traits, which in turn are grouped into 
broader dimensions in a hierarchical fashion. 
Quantitative approaches to classification have a long history 
(Blashfield, 1984; Eysenck, 1944; Foulds, 1976; Lorr, Klett, & McNair, 1963; 
Moore, 1930; Overall & Gorham, 1962; Wittenborn, 1951), especially in 
childhood psychopathology. Two spectra of mental illness, internalizing and 
externalizing, are particularly well-established (Achenbach, Ivanova, & 
Rescorla, 2017), and a third spectrum – thought disorder – has also been 
identified (Keyes et al., 2013; Kotov et al., 2011a; Kotov et al., 2011b; 
Markon, 2010). Recent studies involving more varied types and severity of 
psychopathology have recognized other spectra, including antagonistic and 
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disinhibited externalizing (i.e., divisions of externalizing), detachment, and 
somatoform (Kotov et al., 2011b; Markon, 2010). 
The Hierarchical Taxonomy of Psychopathology (HiTOP)
In 2015, a new consortium dedicated to advancing the Hierarchical 
Taxonomy of Psychopathology (HiTOP) was organized by psychologists and 
psychiatrists with a shared interest in quantitative nosology of mental illness.
Its aim is to develop a common nosology based on existing evidence and 
continuing research with an emphasis on reliability, validity and utility in 
diagnosis and classification. The resulting model – a work still in progress – is
summarized in Figure 1, with a case illustration provided in Box 1. 
At the lowest level of the HiTOP hierarchy are symptoms components 
(tightly-knit groups of symptoms) and maladaptive traits. Each of these is 
designed to be a homogenous dimension. Examples include performance 
anxiety and social interaction anxiety. 
At the next level of the hierarchy are syndromes - constellations of 
related symptoms, signs and traits that strongly co-occur. For example, the 
syndrome of social phobia includes trait submissiveness as well as anxiety 
about both performance and social interactions. Syndromes do not 
necessarily map onto DSM-5 or ICD-10 disorders, but they form the HiTOP 
level that most closely correspond to them. 
At the next level up of the hierarchy are subfactors, reflecting small 
clusters of strongly related syndromes. For example, a fear syndrome 
includes social as well as specific phobia, and also agoraphobia. 
Above this are spectra—broad groups of syndromes and subfactors 
that are distinct from one another yet still related. For instance, distress, 
fear, eating, and sexual problem subfactors are grouped into an overarching 
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internalizing spectrum. Higher levels beyond spectra are recognized in 
HiTOP, up to a general psychopathology factor (p) reflecting overall 
maladaptation (Caspi et al., 2014; Caspi & Moffitt, 2018; Kim & Eaton, 2015; 
Krueger, 2018; Lahey, Van Hulle, Singh, Waldman, & Rathouz, 2011; Selzam,
Coleman, Caspi, Moffitt, & Plomin, 2018; Wade, Fox, Zeanah, & Nelson, 
2018).
Principles for integration into clinical practice
HiTOP provides an empirically grounded framework for organizing 
psychopathology. Already, there is some evidence of enhanced validity and 
reliability compared to more traditional, categorical systems (Bernardini et 
al., 2017; Krueger et al., 2018; Kotov et al., 2017). However, the full value of 
a model like HiTOP can only be realized if it informs and is adopted into 
clinical practice, a remaining barrier to its utility (Tyrer, 2018). Here, we 
articulate three major principles to guide integration of HiTOP into practice, 
as well as their implications and limitations. 
Dimensions with ranges of cutoff scores, not categories. In the HiTOP 
framework, patient psychopathology is no longer described in terms of 
categorical diagnoses. Rather, psychopathology is conceptualized along 
dimensions with varying degrees of severity. This dimensional aspect 
pervades every level of HiTOP, from components and traits through spectra 
and superspectra. HiTOP explicitly acknowledges the clinical reality that no 
clear divisions are empirically supported between most mental disorders and
normality or, oftentimes, between neighboring disorders (e.g., Clark et al., 
2017; Zimmerman et al., 2015). Subsyndromal symptoms are not a 
shortcoming of the HiTOP nosology, but an inherent feature. Moreover, the 
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concept of “diagnosis” is not one of ‘present’ versus ‘absent’, but rather a 
profile that emphasizes the patient’s symptom severity across each 
component, syndrome and spectrum.
HiTOP’s adoption of a dimensional perspective in no way precludes the 
use of categories in clinical practice. For example, it is common in medicine 
to superimpose data-driven categories (e.g., normal, mild, moderate, or 
severe) on dimensional measures (Kraemer, Noda & O’Hara, 2004), such as 
blood pressure or cholesterol. A similar approach can be used with HiTOP. 
The range can be based on a pragmatic assessment of relative costs and 
benefits. For instance, in primary care settings, a more liberal (inclusive) 
threshold can be used for identifying patients requiring more detailed follow-
up. Conversely, decisions about more intensive or risky treatments can 
employ a more conservative (exclusive) threshold. Empirical work has begun
to delineate such ranges for some measures (Stasik-O’Brien et al., 2019), but
much more is needed to cover the full spectrum. Most importantly, HiTOP 
explicitly acknowledges that ranges are pragmatic and not absolute, 
recognizing the need for flexibility in clinical decision making. Categorical 
and dimensional systems can relay equivalent information (Kraemer, Noda &
O’Hara, 2004) so long as cut points are not reified, an approach HiTOP 
explicitly makes clear.  Ultimately, cost-benefit ratios balancing treatment 
resources relative to base rates and potential adverse effects can optimize 
choice of ranges (Kraemer et al., 2012), which we elaborate and illustrate 
more below.
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As this work progresses, clinicians ready to implement HiTOP now can 
use the template of intelligence testing as a guide for making clinical 
decisions. For example, decisions about IQ, a dimensional construct with no 
clear demarcations, involve pairing statistical criteria with impaired 
functioning. IQs lower than 1 – 2 standard deviations (SDs) from the mean 
(i.e., in the 85 – 70 range) commonly serve as the basis for receiving 
assistance and resources. Similarly, a statistically based criterion for 
psychopathology dimensions can be paired with ratings of life-functioning or 
clinical risk (e.g., suicide potential) to guide intervention. Clearly, this 
approach requires validation, but it is rational starting place from which to 
proceed.
In practice, this strategy could be partially implemented now. Several 
existing assessment instruments congruent with HiTOP are readily available 
to clinicians (see https://psychology.unt.edu/hitop), although no single one 
covers the full range of the model (see “Barriers” for more on how to 
address). Almost all measures we list have normative data, which would 
allow patients’ scores to be converted into standardized T-scores. These 
scores can then be used as a starting point for clinical decisions (e.g., 60 – 
64 being mild, 65 – 69 moderate, 70+ severe).  This approach has 
advantages but also barriers (e.g., time, effort, and financial cost) reviewed 
more below.  For now, we highlight this strategy simply to illustrate that 
assessment of psychopathology using dimensions is possible now and 
consistent with other areas of medicine that treat dimensional phenomena.
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Hierarchical nature of illness. Classification in HiTOP is organized and 
conceptualized hierarchically based on empirical evidence. This feature 
acknowledges that some clinical questions concern narrow forms of 
psychopathology (e.g., auditory hallucinations in psychotic disorder), 
whereas others cut across conditions (e.g., elevated neuroticism as a 
vulnerability to all internalizing disorders; Shackman et al., 2016). HiTOP’s 
hierarchical organization permits a step-wise approach to assessment, 
beginning with brief screening of higher-order spectra, and then – based on 
time and need – progressing to more focused assessments in order to 
characterize the subfactors, syndromes, and symptoms/traits within each 
spectrum more fully. This enables clinicians to target a specific level for 
assessment or intervention. 
This flexibility may be particularly important as a nosology is used in 
settings with different resources and needs. For example, in acute settings, 
where assessment time may be limited and clinical decision-making focused 
on emergent or urgent care (e.g., suicide risk; mania), providers can limit 
assessment to the focused set of six higher-level spectra or to the most 
relevant lower-level ones. Cardinal or prototypic symptoms can indicate 
which spectra are elevated—analogous, for example, to diagnosing an 
unspecified mood disorder. Elevations of higher level spectra can guide 
treatment planning by indicating the need for more in depth assessment of 
spectra components and traits later, or by signaling cross-cutting processes 
common to all forms of psychopathology in this domain; alternatively or in 
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addition, clinicians can focus on the most relevant lower-level components 
relevant to that setting. In longer-term settings, or with more time, clinicians 
can cascade down the hierarchy to flesh out more nuanced profiles of all the 
narrow, lower-order symptoms and traits (e.g. social versus situational 
phobia of a fear syndrome).
The flexibility afforded by HiTOP’s hierarchy, however, naturally raises 
questions about the optimal level for assessment and intervention.  For 
example, a clinician could decide to intervene at higher levels of the 
hierarchy, targeting symptoms and processes common to all of the 
components that constitute a spectrum. The Unified Protocol Transdiagnostic
Treatment for Emotional Disorders (Barlow et al., 2017) is one such 
intervention focused on vulnerability processes (e.g., increased negative 
affect, cognitive processing biases, behavioral avoidance) that are thought to
underpin many symptoms within the internalizing spectrum. Similarly, 
selective serotonin reuptake inhibitors have been shown to be efficacious for 
several internalizing conditions (Martinez, Marangell, & Martinez, 2008) and 
appear to be effective for subfactors of the spectra (i.e., fear, distress and 
some eating pathology). Efficacy of these transdiagnostic treatments 
suggests shared mechanisms and processes related to higher-level spectra 
may be a parsimonious level for assessment and then intervention, but 
empirical evidence is needed before supporting this hypothesis. Cascading 
benefit of treatments focused on lower order components (e.g., treating 
sleep improves broader syndromes; Taylor & Pruiksma, 2014), for example, 
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means that focusing on specific lower order components may instead prove 
more clinically useful. In our example, a clinician could instead focus on 
addressing specific sleep symptoms using medications (e.g., Kuriyama, 
Honda, & Hayashino, 2014) or psychotherapies (e.g., sleep restriction) with 
narrow targets of action.  
Ultimately, optimal strategy may be to focus first on the spectra, 
because interventions that are efficacious for such fundamental problems as 
negative affectivity or social detachment are likely to provide the patient 
with maximal benefit, and augment this with additional intervention for 
syndromes or components that are elevated relative to the corresponding 
spectrum. However, existing arsenal of spectra-level treatments is limited 
and at present the choice may be pragmatic, depending on options available
for elevated dimensions and on therapist’s expertise in these options.
One final point related to the HiTOP hierarchy and how it affects clinical
practice: HiTOP recognizes the interplay of traits and symptoms (e.g. Klein et
al., 2011 Ormel et al., 2013) and ensures that both are considered in 
treatment.  For example, certain treatments are particularly effective in 
promoting personality change (e.g., Hudson et al., 2015; Robert et al. 2017), 
which in turn can improve other mental health symptoms (e.g. Conrod et al., 
2013; Zinbarg et al., 2008).  Alternatively, explication of traits can guide 
clinicians in matching treatments to patient’s personality vulnerabilities, as 
they have been found to moderate therapeutic process (e.g., traits related to
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agreeableness moderate efficacy of behavioral therapy for distress; Kushner 
et al., 2016; Samuel et al., 2018).
Impairment rated separately. Functional impairment is not tied to each
specific syndrome, but instead is rated separately and reflects global 
impairment (e.g., Range of Impaired Functioning Tool, RIFT; Leon et al., 
1999). HiTOP’s separate rating of impairment recognizes the practical and 
psychometrically questionable challenge of disentangling impairment from 
symptoms (McKnight & Kashdan, 2009; Uestuen & Kennedy, 2009), 
especially when multiple syndromes are present (Gijsen et al., 2001). 
Impairment can continue to be used to assist with clinical decision-making 
(e.g. pairing elevated symptoms with an impairment threshold to determine 
“caseness”), but this is not a necessary condition of the symptom profile. 
The explicit inclusion of an impairment (or distress) requirement in 
traditional nosology for each diagnosis (i.e., the “clinical significance 
criterion”) reflected an attempt to address concerns over false positives and 
has been a source of subsequent debate (e.g., Ustuni & Kennedy, 2009; 
Spitzer & Wakefield, 1999). HiTOP’s conceptual shift away from categories to
dimensions allows for this problem to be solved in another way: empirical 
studies can determine symptom ranges that warrant treatment, and 
validated against a series of criteria, including but not exclusively 
impairment. From a practical perspective, it will take time for this body of 
evidence to develop, and will likely vary across populations.  Until then and 
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even after that, clinicians can pair elevated symptom profiles with a global 
rating of impairment to guide their clinical decisions about the need for care.
  Advantages of HiTOP for clinical practice and their limitations
A more valid and reliable classification system means little if clinicians 
do not use it. Although empirical work is needed to validate them, there are 
at least three ways in which HiTOP has the potential to improve the clinical 
utility of a nosology compared to categorical diagnostic systems, as well as 
limits for each (c.f. Reed, 2010). 
First, it may improve communication. HiTOP’s use of dimensions 
increases reliability (e.g.,15% increased reliability of dimension over 
categories in meta-analyses; Markon, Chmielewski, & Miller, 2011), but it can
improve communication by more precisely relaying symptom severity (i.e., 
percentile scores are now provided relative to population norms for elevated 
dimensions).  In contrast, DSM and ICD provide heterogeneous categories 
with less precision about severity, particularly milder symptoms, although 
efforts have been made to include subthreshold symptom information within 
both systems (Kraemer et al., 2012). HiTOP also provides flexibility to 
communicate in greater or less detail depending on the level of review, 
focusing on a relatively small number of elevated spectra or elaborating on 
specific syndromes, symptoms, or traits as appropriate. The incremental 
benefit of this may be limited given one could do something similar with 
traditional systems (e.g. review diagnostic classes as opposed to individual 
diagnoses). HiTOP’s spectra, however, were derived to be less 
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heterogeneous than diagnostic classes and may be fewer in number (Kotov 
et al. 2017).
Importantly, surveys of clinicians suggest that practitioners find 
dimensional diagnosis informative and workable. For example, clinicians 
surveyed in recent studies rated dimensional descriptions of personality 
pathology as better for communication purposes than traditional diagnoses, 
although not always significantly so (Hansen et al. in press; Glover et al., 
2012; Morey, Skodol, & Oldham, 2014).  
Second, HiTOP may provide clinicians with greater prognostic power 
(Hasler et al., 2004). For example, relative to categorical diagnoses, 
dimensional scores generally show superior prediction of clinical outcomes 
such as chronicity (Kim & Eaton, 2015), functional impairment (Keyes et al., 
2013; Morey et al., 2007), and physical health comorbidities (e.g., Eaton et 
al., 2013). HiTOP constructs also show notable links with significant non-
disorder outcomes. For instance, the association of internalizing disorders 
with suicide appears to be driven primarily by commonalties within the 
spectrum rather than specific disorders (e.g., Eaton et al., 2013). 
Third, HiTOP-based assessments have the potential to better guide 
clinical decision-making and improve outcomes compared to DSM and ICD 
(i.e. enhance the treatment utility of assessment; Hayes, Nelson & Jarrett, 
1987). This is not a forgone conclusions as DSM and ICD have established 
utility: (i) existing treatment guidelines are based on these diagnoses, (ii) 
categorical diagnosis comports with the dichotomous nature of clinical 
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action, and (iii) existing administrative systems rely on traditional diagnoses.
However, this utility has limitations.
(i) Community clinicians frequently do not select treatment according 
to diagnosis (Baldwin & Kosky, 2007; First et al., 2018; Hermes, Sernyak, & 
Rosenheck, 2013; Mohamed & Rosenheck, 2008; Taylor, 2016), instead they 
focus on symptoms and presenting complaints. Recent studies found that 
decision-making of community clinicians is more aligned with HiTOP 
description than with traditional diagnoses (Waszczuk et al., 2017; 
Rodriguez-Seijas et al., 2017; Hopwood et al., 2019). Consequently, HiTOP 
will provide clinicians with normed systematic tools to support their preferred
practices more effectively than informal interviews on which many rely. 
Importantly, reluctance of clinicians to follow DSM-based practice guidelines 
may be a rational choice, given shortcomings of traditional diagnoses. 
Specifically, when predictive power of traditional diagnoses has been 
compared to dimensional diagnoses, traditional diagnoses were often found 
to be inferior (Eaton et al., 2013; Hettema et al., 2005; Kaczkurkin et al., 
2017; Kendler, Prescott, Myers & Neale, 2003; Kotov et al., 2017; Lahey et 
al., 2017; Nelson et al., 2015; Muetzel et al., 2017; Shanmugan et al., 2016; 
Snyder et al., 2017; Vollebergh et al., 2001; Waszczuk et al., 2014). Also, 
limited ability of the DSM to conceptualize comorbidity resulted in clinical 
trials being performed in patients who have little comorbidity (e.g., 
Zimmerman et al., 2002), although comorbidity is the norm and may affect 
treatment profile (e.g., Newman et al., 1998).  Recent efforts to change this 
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have seen more generalizable trials for psychotherapy (Franco et al., 2016), 
but many studies remain focused on unrepresentative cases (Lorenzo- 
Luaces, Zimmerman & Cuijpers, 2018) especially pharmacotherapy trials 
(Franco et al., 2016). Moreover, arguments have been made that traditional 
diagnoses impede development and dissemination of psychotherapy 
(Hofmann & Hayes, 2018).  
(ii) Treatment decisions are categorical (e.g. one either hospitalizes or 
not; cf. Kraemer, Noda & O’Hara, 2004) and a dichotomous diagnosis is 
aligned with this clinical need. However, clinical decision making occurs 
within a complex and nuanced frame and often cannot be reduced to a 
single dichotomy, as choices need to be made about degree of care, provider
and treatment modality (Verhuel, 2005). DSM diagnosis built-in cutoffs may 
be less able to adapt to this multi-layered and multi-sequenced clinical 
decision-making.  HiTOP approach enables specification of multiple ranges 
on a dimension of interest based on direct evidence, and so is more explicit 
about the need for this flexibility. Importantly, recent surveys with improved 
methodology show that clinicians find dimensional diagnoses may better 
help formulate treatment plans (Hansen et al. in press; Glover et al., 2012; 
Morey, Skodol, & Oldham, 2014).  
(iii) DSM and ICD codes are likely to remain the language of 
administrative systems for years to come. HiTOP profile can be translated 
into these codes and we have developed a cross-walk for converting profile 
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to codes (provide url; also see below “Barriers” on how this can be 
addressed). 
At this point, there is consistent but modest evidence that decision 
making of community clinicians aligns better with quantitative diagnoses 
compared to traditional diagnoses and clinicians may find the former to be 
more useful clinically. Also, HiTOPs combination of traits with symptoms, as 
opposed to separate diagnostic categories, can lead to reconceptualization 
of psychopathology that recognizes their frequent interdependence and 
relevance for one another (Goldstein et al., 2018), and make traits a more 
focal point of treatment.  Finally, new treatments may better track the 
structure of HiTOP given its empirical derivation.  For example, HiTOP may 
better map onto adaptive systems (c.f. Harkness et al., 2013), making it 
possible that it also better maps onto treatment mechanisms related to 
them.
However, there is no direct evidence that implementation of HiTOP 
diagnoses in clinical setting will improve treatment outcomes. We 
hypothesize that HiTOP will be a better guide for practitioners to select 
optimal treatment, as it provides richer and more precise description of 
patients, but we need studies that randomize patients to HiTOP diagnosis vs.
assessment as usual to test this possibility directly. 
Also, initial examples of novel treatments that were developed for 
dimensions included in HiTOP and found to be efficacious (e.g., Barlow et al., 
2017; Norton, 2012) are encouraging. However, many more treatments need
23
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to be designed for different elements of HiTOP, including other spectra, and 
evaluated in randomized clinical trials before it will be clear whether HiTOP 
can provide effective guidance to treatment development.
In addition to these three potential advantages and limitations for 
clinical utility, HiTOP also promises to accelerate basic clinical and 
psychotherapy research (Conway et al., 2019; Waszczuk et al., 2018). The 
heterogeneity of DSM-5 disorders weakens and obscures the impact of any 
given treatment for a condition. With HiTOP, clinical interventions can be 
evaluated with respect to their specificity, and rather than simply concluding 
that a treatment is effective for a certain condition or not, one can discern 
the extent to which it is effective at different levels of the HiTOP hierarchy. 
Moreover, HiTOP may better connect with other efforts to advance 
characterization of psychopathology.  For example, Harkness and colleagues 
(2013) have advocated for functional theories that connect psychopathology 
to evolved adaptive systems as opposed to atheoretical descriptions that 
lack generative potential for mental health research. HiTOP’s detailed, 
empirically-derived structure may better scaffold this research. Hofmann and
Hayes (2018) advocate for process-oriented treatments that target specific 
processes that maintain psychopathology. They described how efficacy of 
these treatments is moderated by relevant patient characteristics – 
dimensions that HiTOP seeks to catalogue. The Research Domain Criteria 
(RDoC) framework has been criticized for lacking clinical applicability (Patrick
24
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& Hajcak, 2016), and HiTOP offers clinical dimensions that can be linked to 
RDoC.
Box 1. Case illustration 
Differences between categorical and HiTOP conceptualizations are 
highlighted through a hypothetical case of a 27-year-old woman referred to 
an outpatient practice by a family member concerned about her increasing 
social isolation. Comparisons focus on the more narrow aspects relevant to 
the diagnostic nosology being used. 
Clinical Symptom Presentation
The client presented as guarded, with constricted affect, initially 
providing only cursory answers. In time, she settled into a conversational 
tone and maintained appropriate eye contact. She reported experiencing 
depressed mood most of each day over the last several months. Despite 
sleeping “all the time” she felt constant fatigue that had her wondering if “a 
permanent sleep” might bring relief. She had lost interest in activities, was 
eating less than usual and was attending few social functions. She described 
having had close friendships, but said she had “burned” many of them, in 
part because she said she “uses” her friends to get what she wants. She 
lived alone and was not dating anyone, although she had had brief, chaotic 
relationships with men in the past. She described excitement (i.e., “on top of 
the world”) and “getting carried away” at the start of these relationships, but
said they often became volatile. Some began after excessive drinking, and 
most ended poorly. She persisted with attending family functions, where she 
described feeling evaluated and judged for “looking depressed.” These 
feelings would prompt anxiety and a desire to flee, upon which she did not 
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act. She noted she would sweat, tremble, and become short of breath and 
dizzy at the peak of her anxiety. Although this passed within minutes, she 
was left with a lingering fear that she may be “going crazy.” Even before her 
recent symptoms, she recalled years of feeling worthless in the eyes of 
others. She reported once being sexually abused during adolescence but was
reluctant to elaborate. She did, however, describe being upset when 
reminded of it, and said she avoids the neighborhood where it occurred. 
Categorical nosology approach
Traditionally, a clinician might start with an interview to assess 
symptoms and psychosocial history more thoroughly, conduct a suicide-risk 
assessment, and determine the need to rule out symptoms due to a medical 
condition (e.g. hypothyroidism) or active substance use. A clinician would 
likely conceptualize the presenting problems from various theoretical 
orientations or known risk factors. But at the point of diagnosis, or even 
conceptualization of the presenting symptom profile, the clinician might 
often entertain a more specific series of alternative (differential) diagnoses if 
they are relying on traditional nosology. In our hypothetical case, this would 
include criteria related to at least six classes of disorders from the DSM-5: 
Depressive Disorders, Anxiety Disorders, Bipolar and Related Disorders, 
Trauma- and Stressor-Related Disorders, Substance-Related and Addictive 
Disorders, and Cluster B and C Personality Disorders. In all, these six classes 
contain 40 possible diagnoses, and 88 potential modifiers.
Careful differential review of respective sets of diagnostic criteria takes
time. If time is short or the setting is an acute one (e.g. emergency 
department), diagnoses may be considered provisional (i.e., to be refined 
over the course of treatment), or may focus only on the most prominent 
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condition, comparing the case to prototypes (Martinez et al., 2008), for 
example.
With more time, the clinician can review symptoms more carefully to 
reach a diagnosis. In our hypothetical case, the clinician takes the time to 
assess relevant criteria and settles on six traditional diagnoses, remaining 
provisional with respect to a personality disorder: F32.1 Major Depressive 
Disorder, single episode, Moderate; F43.10 Post-Traumatic Stress Disorder, 
F40.10 Social Anxiety Disorder, and F41.0 Panic Disorder; provisionally, 
F60.0 Borderline Personality Disorder, F60.6 Avoidant Personality Disorder.
The clinician would discuss these initial formulations and diagnoses 
with the patient and review treatment options. Each of the six diagnoses has 
evidence-based therapies, and there is no clear direction for prioritization, so
the clinician may decide to sequence treatment, or to apply a 
transdiagnostic one. It is important to realize that there is nothing in these 
traditional nosologies per se to suggest one approach or the other. To the 
degree the clinician believes that the diagnoses are valid representations of 
different diseases, this might suggest each disorder requires its own 
treatment, although it does not require it either. Supposing that the patient 
expressed a preference for psychotherapy above medications, the clinician 
might begin with cognitive behavior therapy (CBT) for depression, followed 
by CBT for social anxiety and prolonged exposure therapy for PTSD, 
reserving the possibility of Dialectical Behavior Therapy (DBT) for the 
provisional borderline personality disorder diagnosis. To the degree that 
indicators of avoidant personality disorder do not resolve after treating the 
social anxiety disorder, it would require another treatment if a sequenced 
approach based on diagnosis was followed. Finally, a clinician would 
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coordinate care with other health professionals, and provide for ongoing 
monitoring (Gelenberg et al., 2010). 
HiTOP approach
How would clinical assessment and decision-making differ with a HiTOP
approach? As before, a clinician would conduct a diagnostic interview, 
including a suicide-risk assessment, and rule out symptoms due to a medical
condition or active substance use. As before, the assessment can occur 
within the larger context of a theoretical orientation or evidence-based 
approach (e.g., Hunsley & Mash, 2007).  However, with HiTOP the client’s 
presenting symptoms are understood from a fundamentally different 
diagnostic perspective. The clinician does not screen for diagnostic rule-outs 
related to the fit of presenting symptoms to a specific diagnostic category. 
Rather, presenting symptoms are conceptualized as related to one another, 
with varying degrees of specificity, in a hierarchical scheme. 
A clinician could begin by screening for problems within the six higher-
level spectra. In acute settings (e.g. emergency department again) where 
time is limited, the assessment may not progress in detail past this level, 
with the clinician determining elevations for each spectra based on cardinal 
or prototypic symptoms, or by noting relevant lower-level symptom 
components (e.g., suicidality). As time permits, however, elevated spectra 
scores would prompt more nuanced assessment at lower levels of that 
branch of the hierarchy. In this way, the diagnostician can drill down further 
depending on the level of detail they wish to achieve. They would also rate 
psychosocial impairment globally, regardless of symptoms. 
In our hypothetical case, the clinician is in a setting with time for 
detailed assessment. They may initially opt to screen the six spectra and 
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psychological functioning with a questionnaire or brief interview. Using self-
report measures would allow the clinician to contrast presenting symptoms 
to population-based norms. For example, the first step could be to routinely 
administer the Personality Inventory for DSM-5 – Brief Form (PID-5-BF; 
Krueger et al., 2012), a 25-item measure of pathological traits that broadly 
surveys from several of the HiTOP spectra. It can be used to provide a quick 
overview of elevated internalizing problems (Negative Affectivity) and 
antagonistic externalizing problems (Antagonism), and confirm absence of 
elevations on other spectra (e.g. thought disorder, as indexed by the PID-5-
BF Psychoticism scale). The clinician would also rate the degree of global 
impairment through an interview or questionnaire (e.g., Disability 
Assessment Schedule; WHO, 2000).
Based on initial screening and interviews, the clinician could then flesh 
out a more specific and nuanced profile of the lower-level dimensions. More 
targeted measures or scales can be administered since these allow client 
scores to be more easily contrasted with community-based norms (e.g., for 
the case above, the Inventory of Depression and Anxiety Symptoms [IDAS-II; 
Watson et al., 2012] measures specific subdimensions of internalizing 
symptomatology; the brief form of the Externalizing Spectrum Inventory [ESI-
BF; Patrick, Kramer, Krueger, & Markon, 2013] has antagonism-related 
symptom subscales; PID-5 has additional scales related to Negative Affect 
and Antagonism). For the hypothetical case, administering these instruments
would likely reveal elevations on subscales related to dysphoria, appetite 
loss, suicidality, insomnia, panic, social anxiety, traumatic intrusions and 
traumatic avoidance, as well as elevated traits of emotional lability, 
alienation, and manipulativeness. 
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On the assessment report, the clinician would profile the six spectra, 
indicating which are elevated and providing percentile scores based on 
normative comparisons when available. Within each spectrum, the clinician 
would note elevations on lower-order symptom and trait dimensions, also 
referenced to established norms when available. For example, our 
hypothetical case would report “Internalizing Spectrum, Severe,” followed by
specific lower order symptoms and traits, with norm-based percentiles 
provided for each (as available). Table 1 briefly contrasts what diagnoses 
based on the DSM-5 versus HiTOP would look like, and Figure 2 illustrates 
what a HiTOP profile could look like (i.e., spectra are on the left and more 
narrow components follow).
The shift in classification carries over to treatment planning. Rather 
than distinct diagnostic categories, a clinician would conceptualize two broad
domains for treatment (i.e. internalizing and antagonistic externalizing in the
example), with lower-order symptoms and traits characterizing nuances 
within each. With respect to treatment planning, the clinician has flexibility 
to target narrow symptoms or broader spectra depending on tools at his or 
her disposal, patient preferences (in this case, preference for 
psychotherapy). HiTOP’s structure naturally suggests the use of 
transdiagnsotic approaches, given that all of the internalizing symptoms, for 
example, cluster together. In our illustrative case, the clinician decides to 
use a broad approach for the internalizing symptoms (i.e., transdiagnostic 
Unified Protocol discussed earlier; Barlow et al., 2017), but a narrow 
intervention for antagonistic externalizing symptoms (i.e., techniques from 
interpersonal therapy to target trait manipulativeness).
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The HiTOP approach to treatment planning in this illustrative case has 
at least four benefits. First, comorbidity no longer raises questions over the 
valid distinction between disorders, but becomes part of the 
conceptualization. In the illustration, rather than multiple distinct disorders, 
specific symptoms and traits are conceptualized as part of an internalizing 
spectrum. Clinicians who use a single therapy for multiple disorders may 
already be conceptualizing disorders this way. Second, HiTOP resolves the 
issue of heterogeneity, enabling clinicians to target narrow dimensions if 
they choose. For example, rather than focus on a heterogeneous category 
such as borderline personality disorder, a clinician can target specific 
symptoms or traits (e.g., target trait manipulativeness in the illustrative 
case). The ability to flexibly determine the level at which to intervene 
becomes a feature of the classification. Third, HiTOP explicitly incorporates 
subthreshold symptoms into its nosology, rather than relying on a single 
cutoff for diagnosis. In our hypothetical case, for example, clinicians could 
monitor appetite loss as part of the overall treatment plan, and address this 
if weight loss becomes significant. Fourth, traits from the HiTOP system offer 
prognostic information to assist planning (Bagby, Gralnick, Al-Dajani, 
Uliaszek, 2016) – for example, highlighting the degree to which antagonistic 
externalizing traits may affect the therapeutic alliance (Hirsh, Quilty, Bagby 
& McMain, 2012). 
Barriers to the integration of HiTOP into practice
Despite its promise and advantages, integration of a diagnostic model 
like HiTOP into clinical practice faces significant barriers and concerns. We 
address eight prominent questions raised by these concerns here. 
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Is HiTOP-consistent classification harder to communicate to patients 
and providers? HiTOP communicates clinical problems based on 
psychopathological profiles rather than categorical diagnoses. Explaining the
meaning of higher-level profiles can be more parsimonious than listing 
multiple, comorbid diagnoses. In turn, lower levels are analogous to 
communicating about symptoms. The hierarchical structure accommodates 
clinical complexity but also provides a flexible model for conceptualization 
and communication. The use of profiles, however, may initially present as 
more complicated for clinicians who are not accustomed to them.  We 
believe familiarity can resolve this over time. Although not directly relevant, 
clinicians find dimensional models of personality acceptable or even 
preferred for communicating (Hansen et al. in press; Glover et al., 2012; 
Morey, Skodol, & Oldham, 2014), suggesting HiTOP’s effects on 
communication can be overcome as barrier to integration. 
Are there measures for assessing psychopathology with HiTOP? Many 
measures consistent with HiTOP nosology are already widely available and 
used in clinical practice (e.g., Achenbach et al., 2017; Clark, Simms, Wu, & 
Casillas, 2014; Krueger, et al., 2012; Morey, 2007a). For example, the 
Achenbach System of Empirically Based Assessment (ASEBA) originated in 
the 1960’s in work with children and revealed dimensional syndromes 
organized into the higher-order groupings of Internalizing, Externalizing, 
Severe and Diffuse Psychopathology (Achenbach et al., 2017). Based on 
subsequent work over 50 years, ASEBA now has measures with norms that 
cover the lifespan (Achenbach et al., 2017). A HiTOP website 
(https://psychology.unt.edu/hitop) provides examples of other measures 
consistent with HiTOP. 
32
HIERARCHICAL TAXONOMY OF PSYCHOPATHOLOGY
However, no single measures listed on our website fully capture the 
HiTOP model.  Several can be combined to cover most of it, and the 
consortium is piloting versions of these batteries (available upon request).  
The consortium is also in the middle stages of rigorously developing a free, 
omnibus HiTOP instrument, which is being developed and tested at multiple 
sites with diverse samples.
Will HiTOP-based assessment take too long or not be feasible? The 
hierarchical nature of HiTOP allows clinicians to take a stepwise approach, 
starting at higher levels and cascading downward as time permits and need 
requires. Much like a classic “review of systems” performed in general 
medicine (cf. Harkness et al., 2013), such a stepwise approach facilitates 
comprehensive evaluation at higher levels, which can be more efficient than 
review of criteria for multiple categorical disorders.
Moreover, many components can be assessed by self-report measures 
described earlier, which can be administered and scored simply and 
efficiently (although interviews are also available for many domains, if 
preferred). Multi-modal assessments remain preferred (e.g., McCrae, 2013) 
but skepticism about use of self-report (e.g., Huprich et al., 2011; Westen, 
1997) may be overstated (Samuel et al., 2013; Samuel, Suzuki & Griffin, 
2016).  In short, HiTOP’s reliance on reliable, validated self-report 
instruments can mitigate the issue of feasibility by reducing provider burden 
without necessarily compromising validity.
Nevertheless, adoption of a fully dimensional system will face the 
burdens of administering and scoring dimensional measures. To overcome 
this barrier, integrating assessment instruments with newer technologies is a
critical next step. Computerized adaptive testing, and administration via 
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internet portals or smartphone applications, can reduce burden and increase 
the clinical utility of dimensional systems. Such second-generation advances 
exist for several instruments congruent with HiTOP, but more work is needed
to make these fully available and easily integrated into practice.
Are there validated “cutoffs” for use in determining the need for 
treatment? With only a few exceptions, empirically-determined cutoffs for 
determining who needs treatment remain rare for HiTOP as well as for DSM-
5 or ICD-10. Several diagnoses based on cutoffs for the current categorical 
system (i.e., DSM/ICD) have been shown to have problems with reliability in 
formal field studies (Carragher et al., 2014) and cutoffs have been criticized 
on psychometric grounds (Finn, 1982). This serves as a compelling impetus 
for HiTOP: Using a hierarchical and dimensional system of measurement 
allows one to fine-tune assessments based on research in the field, and 
move away from a “one size fits all” cutoff inherent to dichotomous 
diagnoses. Classic perspectives on assessment strongly emphasize that test 
validity is relative to designated purposes, and dimensional approaches allow
‘cutoffs’ to be customized for particular assessment objectives. Though this 
will take time, we believe that the resulting ranges and cutoffs may be 
clinically meaningful, show increased sensitivity, and may fit more naturally 
into “stepped-care” models (cf. van Straten et al., 2015).
Can HiTOP be used in conjunction with DSM/ICD-based assessment 
protocols? Some HiTOP principles can be integrated with DSM/ICD-based 
assessments. DSM-5 began taking steps toward HiTOP-consistent nosology 
by grouping similar syndromes into diagnostic classes, such as the autism 
and schizophrenia spectra, and the DSM-5 alternative model for personality 
disorder is a trait-based diagnostic system. Many other DSM-5 disorders 
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could be regrouped into classes consistent with HiTOP spectra, and 
conceptualized as part of a hierarchy (e.g. grouping depressive with 
generalized anxiety disorder as part of a distress subfactor). Disorder criteria
can also be scored continuously as symptom counts and used as severity 
indicators, as is done now for DSM-5 substance use disorders. Doing so 
provides some benefit over categories, although resulting scales would not 
map precisely onto HiTOP’s dimensions. Such modifications would not be 
equivalent to a HiTOP approach, but nonetheless demonstrate how clinicians 
could begin to integrate HiTOP’s underlying principles into case 
conceptualization without changing their assessment protocols.
Is HiTOP appropriate for youth? A number of studies have supported 
components of a hierarchical model in youth (Achenbach et al., 2017; 
Laceulle, Vollebergh, & Ormel, 2015; Lahey et al., 2011) and assessment 
tools exist for diverse ages. ASEBA, for example, has instruments specifically
for children. Other instruments consistent with HiTOP have adolescent 
versions (e.g., Butcher et al., 1992; Linde, Stringer, Simms, & Clark, 2013; 
Morey, 2007b). Hence, HiTOP-consistent approaches to classification can be 
integrated into the assessment and treatment of youth.
How can a clinician using HiTOP be reimbursed? Reimbursement is 
often tied to ICD codes (i.e., an ICD diagnostic code must be submitted for an
encounter in order for the clinician to get paid). Every diagnostic grouping in 
ICD includes an “unspecified” category for cases that do not meet the 
diagnostic criteria for a specific disorder within that grouping or for patients 
for whom the clinician chooses not to provide a specific code. Thus, the 
appropriate “unspecified” categories that correspond to the patients 
presenting symptoms could be used to meet administrative requirements. 
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The HiTOP Clinical Translation Workgroup has developed a free HiTOP-ICD 
crosswalk (URL: ADD) to allow clinicians to use HiTOP in their practice by 
linking HiTOP domains to ICD codes for billing and administrative purposes 
(e.g., the illustrative case described with the profile in Figure 2 could be 
given ICD codes F39, F41.9, F51.9, F60.9). This approach has limitations, but 
can provide a solution until billing and administrative procedures are better 
aligned with quantitative nosology.
8. How can HiTOP be incorporated into training? With time, we 
anticipate the possibility that diagnostic manuals may transition to a 
dimensional approach along the lines of HiTOP. For example, ICD recently 
adopted a more dimensional perspective for personality.  However, until that
time, courses in psychopathology will continue to be organized around 
categorical DSM/ ICD models, which creates training challenges. We suggest 
a transition with respect to training that mirrors the transition in clinical 
practice. The HiTOP model incorporates DSM-like constructs, breaking them 
down into smaller (symptom component) and larger (spectra) units in a 
hierarchical fashion. In our experience, this mapping is intuitive, making it 
straightforward to teach students the DSM categories for practical and 
perhaps temporary purposes, while familiarizing them as well with evidence-
based hierarchical models. The connection between dimensional and 
categorical diagnosis is also intuitive. As discussed earlier, it is common for 
students to learn how to apply cut scores along recognized continua, such as
blood pressure or IQ. Thus, students can be taught to think about diagnostic 
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cut scores for psychopathology diagnosis in the same way: diagnostic 
thresholds are indicators not of people who can be classified as qualitatively 
different from the healthy, but of relative severity on continua that suggest 
varying need for treatment. 
Conclusions
Features of an alternative classification system based on quantitative 
methods are becoming increasingly clear and offer advantages over 
traditional nosology. The hierarchical-dimensional classification approach 
described here – the HiTOP system – is characterized by six overarching 
spectra of mental illness, each encompassing more narrowly defined and 
more homogenous elements, consisting of narrower symptom components 
and traits. Our aims in this article have been to describe major principles for 
integrating HiTOP into clinical practice, introduce tools that can assist 
clinicians, and illustrate what such an integration might look like. HiTOP has 
several advantages over traditional nosology that may improve its clinical 
utility, and clinicians may already be practicing with several of its principles 
in mind.  However, the system shares some limitations of traditional 
nosology and may introduce new ones, so more work is needed to prove its 
utility for improving patient care.
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Table 1. Illustrative Diagnoses for DSM-5 versus HiTOP
DSM-5 HiTOP 
Major Depressive Disorder, single 
episode, Moderate
Post-Traumatic Stress Disorder
Social Anxiety Disorder
Panic Disorder
Borderline Personality Disorder
Avoidant Personality Disorder.
Internalizing, Severe (98%)
Prominent symptoms: 
dysphoria, appetite loss, 
suicidality, insomnia, panic, 
social anxiety, traumatic 
intrusions and avoidance; 
emotional lability
Antagonistic Externalizing, Mild 
(92%) 
Prominent traits: 
manipulativeness
Note. Percentiles reflect scores relative to normative distribution and would 
come from test scores when available.
4
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Figure 1. Hierarchical Taxonomy of Psychopathology model
Note: Dashed lines indicate elements of the model that are included on provisional basis. The level 
“Syndromes/Disorders” is included to indicate the approximate level of in the hierarchy most closely corresponding to 
current disorders; however, precise syndromes remain to be established in the model.
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Figure 2. HiTOP profiles for the illustrative case
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